A recently approved twice-yearly injection to prevent HIV may warrant a higher price, but thousands of dollars more?  CVS Caremark’s chief medical officer calls on Gilead Sciences to lower the $28,000 ...

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

Currently available medications could be enough to end the HIV epidemic in the United States, provided people can access and ...

The federal government shutdown has brought respiratory virus surveillance to a halt at the national level, leaving local ...

The drug can be produced for as little as $25 per person annually, but even at $2000 per person, it can reduce new US infections almost entirely, a researcher says.

Actor and activist Javier Muñoz joined public-health leaders in Atlanta to unveil the #CutsKill Quilt and demand Congress protect HIV funding that advocates say saves lives.

The incidence of dermatologic disease among people with HIV decreased from 2011 to 2023, but it remains prevalent.

We finally have the technology, infrastructure, and the political will to end the US HIV epidemic, write the Brown University ...

The interdisciplinary research team at the School of Medicine will work together to explore the effects of factors like ...

Even as the medical care needed to treat patients with well-controlled HIV has been significantly streamlined, complex ...

ATLANTA (AP) — CDC researchers are being forced to skip a pivotal conference on infectious disease this week due to the ...

A decade after a historic HIV outbreak in Indiana, syringe programs that helped contain the crisis are at risk of ...